The review revisited SUSTAIN-6, where semaglutide-treated patients showed a hazard ratio of 1.76 for retinopathy complications compared with placebo. The discussion has since shifted toward whether rapid metabolic changerather than direct retinal toxicitymay explain the signal
Science-backed GLP-1 Support to help support natural fullness, appetite balance, and metabolic health.* Made with Trpti OEA, CQR-300, and Chromium to work with your bodys natural fullness signals
Conclusion: A Thoughtful Approach to Innovation GLP-1 microdosing represents an intriguing development in metabolic medicine, offering the potential for personalized treatment with reduced side effects
Staying on Zepbound wont be simple, though
Lets look at what GLP-1 agonists are, why we use them, and how you can manage side effects